---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-24-000324"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2024-03-28T23:59:59+00:00"
generated_at: "2026-06-04T05:50:42.925200+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# IGC Pharma announces $3M private placement with Bradbury Asset Management at $0.34/share

## Summary
- Issued 8,823,529 unregistered common shares at $0.34/share to Bradbury Asset Management on March 22, 2024.
- Gross proceeds of $3 million to fund general corporate purposes and advance investigational drug IGC-AD1.
- Closing subject to customary conditions including NYSE approval; shares not immediately tradable.
- After issuance, IGC will have ~75,365,061 shares outstanding; piggyback registration rights granted.

## SEC filing metadata
- accession: 0001185185-24-000324
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2024-03-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518524000324/0001185185-24-000324-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518524000324/igcpharma20240326_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-24-000324
- JSON: https://secwatch.observer/filing/0001185185-24-000324.json
- Plain text: https://secwatch.observer/filing/0001185185-24-000324.txt

## Key facts
- Material Agreements
  IGC Pharma, Inc. entered into 2024 Share Purchase Agreement with Bradbury Asset Management (Hong Kong) Limited valued at $3,000,000 (effective 2024-03-22).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Bradbury Asset Management (Hong Kong) Limited
  - Value: $3,000,000
  - Effective: 2024-03-22
  source text: On March 22, 2024, IGC Pharma, Inc. (“IGC” or the “Company”) entered into the 2024 Share Purchase Agreement (the “2024 SPA”) with Bradbury Asset Management (Hong Kong) Limited (“Bradbury”) relating to the sale and issuance by our company to the investors of an aggregate of 8,823,529 shares of our common stock, for a total purchase price of $3,000,000
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518524000324/0001185185-24-000324-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.